The World Health Organization (WHO) has moved to secure an initial 230 million doses of Covid-19 vaccines for Africa, while also advocating that any vaccine in development should also be tested on the continent.
This is as the African continent hopes to benefit from the global vaccine allocation plan, known as COVAX, which aims to help purchase and distribute equitably, 2 billion doses of approved vaccines by the end of 2021.
This was disclosed by the Programme Area Manager for WHO Africa, Richard Mihigo, to an online news conference.
Mr. Mihigo said, “This (initial batch) will cover 20% of the African population, initially prioritizing those who are the front line, health care workers, then expanding to cover vulnerable groups.’’
The development comes as the number of COVID-19 infections on the continent stood at 1,267,656 by Thursday afternoon, according to the Africa Centres for Disease Control and Prevention.
Figures from the agency also showed that the continent has reported 30,294 fatalities as some countries continues to see a steady increase in infections.